SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-029327
Filing Date
2018-11-13
Accepted
2018-11-13 16:32:01
Documents
65
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q torc-10q_20180930.htm 10-Q 1126061
2 EX-10.1 torc-ex101_41.htm EX-10.1 87850
3 EX-31.1 torc-ex311_7.htm EX-31.1 15273
4 EX-31.2 torc-ex312_8.htm EX-31.2 15367
5 EX-32.1 torc-ex321_6.htm EX-32.1 7799
  Complete submission text file 0001564590-18-029327.txt   5583475

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT torc-20180930.xml EX-101.INS 1305343
7 XBRL TAXONOMY EXTENSION SCHEMA torc-20180930.xsd EX-101.SCH 44875
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE torc-20180930_cal.xml EX-101.CAL 35100
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE torc-20180930_def.xml EX-101.DEF 188694
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE torc-20180930_lab.xml EX-101.LAB 333427
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE torc-20180930_pre.xml EX-101.PRE 288014
Mailing Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116 617-482-2333
resTORbio, Inc. (Filer) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38359 | Film No.: 181178440
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1